Skip to Navigation Skip to Main Content
Thomson Reuters Westlaw Maryland Code and Court Rules
  • Home
  • Search
  • Help
Home Health—General Title 2. Maryland Department of Health

Subtitle 8—Prohibition Against Price Gouging for Essential off–Patent or Generic Drugs

  • MD Health Gen T. 2, Subt. 8, Refs & Annos
  • § 2–801. Definitions
  • § 2–802. Price Gouging in Sale of an Essential off-Patent or Generic Drug Prohibited
  • § 2–803. Notification of Price Increase to Attorney General;  Procedures
Privacy Accessibility Maryland State Law Library
Thomson Reuters